Skip to main content

Table 1 Tissue sampling and heterogeneity assessment

From: Quantitative assessment of the spatial heterogeneity of tumor-infiltrating lymphocytes in breast cancer

Characteristic

Number

%

Age at diagnosis

 ≥50

23

69.7

 <50

10

30.3

Histological grade

 1

0

0

 2

20

60.6

 3

13

39.4

Tumor size

 <2 cm

6

18.2

 2–5 cm

25

75.8

 ≥5 cm

2

6.1

ER status

 ER positive

23

69.7

 ER negative

10

30.3

PgR status

 PgR positive

19

57.6

 PgR negative

14

42.4

HER2 status

 HER2 positive

5

15.2

 HER2 negative

28

84.8

  1. Whole tissue serial sections of core biopsies from different regions of the same cancer were prepared and multiple fields of view (FOV) were assessed in each section
  2. ER estrogen receptor, PgR progesterone receptor. HER2 human epidermal growth factor receptor 2